Alivexis - Crunchbase Company Profile & Funding

Q: Where is Alivexis's headquarters?

Alivexis is located in Minato, Chiba, Japan.

Q: Who invested in Alivexis?

Alivexis has 16 investors including Keio Innovation Initiative And UTokyo Innovation Platform.

Q: When was the last funding round for Alivexis?

Alivexis closed its last funding round on obfuscated from a Series C round.

Q: How much funding has Alivexis raised to date?

Alivexis has raised obfuscated.

Overview

Alivexis

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Alivexis

CB Rank

32904

Alivexis is a biotechnology company that engages in the research and development of custom medicine for the pharmaceutical industry.

Founded

obfuscation

Private

Series C

Minato, Chiba, Japan

11-50

alivexis.com/

Biotechnology

Clinical Trials

Medical

Pharmaceutical

Funding Rounds

Series C

OBF

obfuscation

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Suguru Roy Kimura: Founder, CEO & Representative Director
Past Role: Schrödinger, Principal Scientist
Kazuki Ohno: Cofounder & President

Details

Legal Name

Alivexis, Inc.

Also Known As

Modulus Discovery

Operating Status

Active

Company Type

For Profit

Founders

Kazuki Ohno, Kimura Shun, Suguru Roy Kimura

About the Company

Modulus Discovery is a private Tokyo-based preclinical stage drug discovery company focused on rapid design and generation of small molecule clinical candidates for a range of high-value disease targets through the use of its cutting-edge computational drug discovery expertise and unique biology insights. The international team at Modulus is

comprised of drug design and disease biology experts with previous R&D experience at global pharmaceutical, biotechnology , and computational technology firms.

Phone Number

+81 3-6868-4547

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

ModBind™ Computational Drug Discovery Platform

A computational platform that uses supercomputing, physics-based simulations, and machine learning to pre-screen protein targets and chemical compounds for drug discovery.

Cathepsin C Inhibitor Program (MOD06051)

A non-covalent inhibitor targeting Cathepsin C to regulate neutrophil protease activity, aimed at treating neutrophil-mediated inflammatory diseases such as ANCA-associated vasculitis.

Research & Development

Alivexis is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Alivexis	6	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Alivexis	6	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Alivexis	6	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Alivexis	6	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Alivexis	6	obfuscated obfuscation	—	Series C

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Alivexis	6	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Alivexis	6	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Alivexis	6	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Alivexis	6	obfuscated obfuscation	—	Series C
obfuscated obfuscation	Series C - Alivexis	6	obfuscated obfuscation	—	Series C

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Keio Innovation Initiative	—	Series C - Alivexis	—
Keio Innovation Initiative	—	Series C - Alivexis	—
Keio Innovation Initiative	—	Series C - Alivexis	—
Keio Innovation Initiative	—	Series C - Alivexis	—
Keio Innovation Initiative	—	Series C - Alivexis	—